OncoSec Medical Inc (ONCSQ)

[chmcnfunds]

It appears that the presentation tomorrow may be more revealing:

"Dr. Adil Daud, principal investigator and co-director of melanoma research at the University of California San Francisco School of Medicine, will be presenting an update to OncoSec's Phase II melanoma immune response data, which will include IL-12 expression findings in a presentation titled "Gene Electrotransfer in Solid Tumors." This presentation will take place on Friday, October 4 at 1:00 p.m. EST."

ONCS